Registered South Africa · SAHPRA

MENINGOCOCCAL VACCINE ASPEN

N. MENINGITIDIS GROUP A POLYSACCHARIDE ,N. MENINGITIDIS GROUP C POLYSACCHARIDE ,N. MENINGITIDIS GROUP Y POLYSACCHARIDE , N.MENINGITIDIS GROUP W POLYSACCHARIDE , N.MENINGITIDIS GROUP X POLYSACCHARIDE

59/30.2/0240

What it does

Group is a medication used to treat various health conditions. It helps manage symptoms and improve overall health.

Commonly used for: specific health condition 1, specific health condition 2

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
59/30.2/0240
Registration date
2026/03/10
Expiry date
-
Status
Registered
Active ingredient
N. MENINGITIDIS GROUP A POLYSACCHARIDE ,N. MENINGITIDIS GROUP C POLYSACCHARIDE ,N. MENINGITIDIS GROUP Y POLYSACCHARIDE , N.MENINGITIDIS GROUP W POLYSACCHARIDE , N.MENINGITIDIS GROUP X POLYSACCHARIDE
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Country of origin
-

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:30:28 · updated 2026-09-23 04:12:36

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.

About group

Group is a medication used to treat various health conditions. It helps manage symptoms and improve overall health.

What it treats

  • specific health condition 1
  • specific health condition 2

How it works

Group works by affecting certain processes in the body to relieve symptoms and improve health.

Who it's for

This medication is for individuals suffering from specific health conditions as advised by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About meningitidis

Meningitidis refers to a type of bacteria that can cause meningitis, an infection of the protective membranes covering the brain and spinal cord.

What it treats

  • meningitis (meningococcal infection)

How it works

Meningitidis bacteria invade the body and can cause inflammation of the protective layers around the brain and spinal cord, leading to serious health issues.

Who it's for

This condition can affect anyone, but it is particularly dangerous for young children, teenagers, and individuals with weakened immune systems.

Cautions

  • • Seek immediate medical attention if symptoms such as severe headache, stiff neck, or fever occur.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About polysaccharide

Polysaccharide is a type of carbohydrate that can be found in various forms and is used in different treatments.

What it treats

  • nutritional support
  • wound healing
  • gastrointestinal issues

How it works

Polysaccharides provide energy and support bodily functions, and some types may help in healing and digestion.

Who it's for

Polysaccharides may be used by people needing extra nutrition or support for healing.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: group

Group is a term that generally refers to a category of medications that share similar pharmacological properties or therapeutic uses. Commonly, groups of drugs are classified based on their mechanism of action, chemical structure, or the conditions they are used to treat. Examples include antihypertensives, analgesics, antibiotics, and antidiabetics. The specific characteristics of a drug group can vary widely depending on the individual drugs within that group, including their efficacy, safety profiles, and side effects.

Dosage

Children: Refer to specific drug monographs for detailed paediatric dosage information, as this will also vary widely among drugs within any given group.

Adults: Refer to specific drug monographs for detailed dosage information, as this will vary widely among drugs within any given group.

Mechanism of action

The mechanism of action for drugs within a group can vary. For example, antihypertensive drugs may work by relaxing blood vessels, reducing heart rate, or decreasing blood volume. Analgesics can work by inhibiting pain pathways in the central nervous system or blocking the production of pain-inducing chemicals. Each individual drug within a group will have its specific pathway and target molecules, such as receptors or enzymes, which are involved in its therapeutic effects.

Pharmacodynamics

Pharmacodynamics describes how a drug affects the body. Within any given drug group, the pharmacodynamics can include the drug's affinity for its target receptors, the efficacy in producing a biological response, and the onset and duration of action. For instance, some analgesics may produce rapid relief of pain, while others may have delayed effects. The dose-response relationship, which indicates how the effects of a drug change with varying doses, is also a crucial aspect of pharmacodynamics.

Pharmacokinetics

Pharmacokinetics encompasses the absorption, distribution, metabolism, and excretion (ADME) of a drug. For drugs within a group, pharmacokinetic parameters can differ significantly. Factors such as bioavailability, half-life, volume of distribution, and clearance rates are important for determining dosing regimens and understanding how long a drug will exert its effects in the body. For example, some antibiotics may be rapidly absorbed and cleared, necessitating more frequent dosing, while others may have extended half-lives allowing for less frequent administration.

Pregnancy

The safety of this drug during pregnancy has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: meningitidis

Meningitidis refers to the infection of the protective membranes covering the brain and spinal cord, known as the meninges. It can be caused by various pathogens, including bacteria, viruses, fungi, and parasites. Bacterial meningitis is a serious condition that requires immediate medical attention and is often treated with antibiotics. Common bacterial pathogens include Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b. Preventive measures, such as vaccination, are also available for certain types of bacterial meningitis.

Indications

  • Bacterial meningitis
  • Viral meningitis
  • Preventive vaccination against meningococcal disease
  • Post-exposure prophylaxis in cases of meningococcal infection

Dosage

Children: Refer to the BNF for Children for dosing recommendations, which will vary based on the specific antibiotic used and the age and weight of the child.

Adults: Refer to local guidelines and the BNF for specific antibiotic dosing regimens according to the pathogen identified and clinical presentation.

Mechanism of action

In cases of bacterial meningitis, antibiotics such as penicillins or cephalosporins work by inhibiting cell wall synthesis, leading to bacterial cell lysis and death. In the context of meningococcal meningitis caused by Neisseria meningitidis, meningococcal vaccines stimulate the immune response against the bacteria, allowing the body to mount an effective defense against future infections.

Pharmacodynamics

The pharmacodynamics of antibiotics used in the treatment of meningitis involve their ability to penetrate the blood-brain barrier, which is crucial for effective treatment of central nervous system infections. The efficacy of these agents is often determined by their ability to achieve adequate concentrations in the cerebrospinal fluid (CSF). Vaccines elicit the production of specific antibodies, providing immunity against the pathogens causing meningitis.

Pharmacokinetics

Pharmacokinetics of antibiotics vary depending on their class. For example, penicillins have good distribution in the CSF, especially when inflammation of the meninges is present. The half-life, metabolism, and excretion routes also vary. Vaccines generally stimulate a long-lasting immune response but do not have a conventional pharmacokinetic profile as they do not act like drugs in the traditional sense.

Pregnancy

Meningococcal vaccines are generally considered safe during pregnancy. However, consult healthcare providers for specific cases.

Breast-feeding

The meningococcal vaccine is safe during breastfeeding. Consult healthcare providers for individual assessment.

Storage

Store at 2 to 8 degrees Celsius. Do not freeze. Protect from light.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: polysaccharide

Polysaccharides are large carbohydrate molecules composed of long chains of monosaccharide units bound together by glycosidic linkages. They serve various biological functions, including energy storage and structural support in living organisms. Depending on their structure, polysaccharides can be classified into storage polysaccharides, such as starch and glycogen, and structural polysaccharides, such as cellulose and chitin. In clinical settings, polysaccharides include a variety of natural and synthetic compounds that are utilized for their therapeutic and physiological properties, including as immunomodulators, anticoagulants, and in the preparation of vaccines.

Mechanism of action

Polysaccharides exert their effects through various mechanisms, often involving the modulation of immune responses. For example, certain polysaccharides can act as pathogen-associated molecular patterns (PAMPs) that are recognized by pattern recognition receptors on immune cells, leading to the activation of innate immunity. Additionally, some polysaccharides can enhance the proliferation and activation of lymphocytes, such as T-cells and B-cells, thereby influencing adaptive immune responses. Some polysaccharides also play a role in anticoagulation by inhibiting thrombin and other factors in the coagulation cascade.

Pharmacodynamics

The pharmacodynamics of polysaccharides vary widely depending on their structure and the specific biological pathways they influence. For instance, polysaccharides that act as immunomodulators can increase cytokine production, enhance phagocytosis by macrophages, and promote the differentiation of immune cells, leading to a more robust immune response. Furthermore, polysaccharides can exhibit anti-inflammatory properties by modulating the release of pro-inflammatory cytokines and chemokines. In the case of anticoagulant polysaccharides, their action may involve the binding and inhibition of specific clotting factors, thus preventing thrombus formation.

Pharmacokinetics

The pharmacokinetics of polysaccharides depend on their molecular weight, structure, and route of administration. Generally, polysaccharides are poorly absorbed in the gastrointestinal tract when taken orally due to their large size and complexity. However, certain polysaccharides are designed for parenteral administration, where they can be directly introduced into the bloodstream. Following administration, they may be metabolized by specific enzymes or by gut microbiota. The elimination half-life can vary significantly, influenced by factors such as the degree of sulfation or acetylation, which can affect their

Pregnancy

Polysaccharides are generally considered safe during pregnancy, but specific formulations should be evaluated on a case-by-case basis. Always consult a healthcare provider.

Breast-feeding

Polysaccharides are typically considered safe during breastfeeding, although individual formulations may vary. Consultation with a healthcare provider is recommended.

Storage

Polysaccharides should be stored in a cool, dry place, away from direct sunlight and moisture. Specific storage conditions may vary depending on the formulation.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.